Work

Abstract 2863: TAVO307, a novel ADC targeting CDH17, for the therapy of gastrointestinal cancers

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-2863

Authors: Guangmao Mu, Fulai Zhou, Zhengxia Zha, Sheng Huang, Ying jin, Yuanting Chen, Mark Chiu, Di Zhang

Institutions: Highlight Therapeutics (Spain), Bioarray Genetics (United States), TauRx (United Kingdom)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409636012

Cites:

Cited by: 2

Related to: 10